The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies.

MLA

Cao, Ru-Bo, et al. “The Efficacy and Safety of Antiangiogenesis Tyrosine Kinase Inhibitors in Patients with Advanced Anaplastic Thyroid Cancer: A Meta-Analysis of Prospective Studies.” Medicine, vol. 103, no. 31, Aug. 2024, p. e38679. EBSCOhost, https://doi.org/10.1097/MD.0000000000038679.

APA

Cao, R.-B., Ge, Y., Zhang, W.-X., Lin, G.-H., Kuang, B.-H., & Wang, B.-C. (2024). The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies. Medicine, 103(31), e38679. https://doi.org/10.1097/MD.0000000000038679

Chicago

Cao, Ru-Bo, Yao Ge, Wen-Xuan Zhang, Guo-He Lin, Bo-Hua Kuang, and Bi-Cheng Wang. 2024. “The Efficacy and Safety of Antiangiogenesis Tyrosine Kinase Inhibitors in Patients with Advanced Anaplastic Thyroid Cancer: A Meta-Analysis of Prospective Studies.” Medicine 103 (31): e38679. doi:10.1097/MD.0000000000038679.